About Us
Fresenius Kabi is a global healthcare company committed to improving the lives of critically and chronically ill patients. With more than 43,000 employees across over 100 countries, the company provides a broad portfolio of medicines, technologies, and services focused on high-quality and lifesaving patient care.
Its business areas include Biopharma, with biosimilars for autoimmune diseases and oncology; Clinical Nutrition, offering enteral and parenteral nutrition products; and MedTech, providing infusion pumps, cell and gene therapy devices, and other medical technologies. Fresenius Kabi is also a global leader in blood collection products and provides intravenous generic medicines and infusion fluids used in emergency medicine, surgery, oncology, and intensive care.
Combining healthcare expertise, innovation, and technology, Fresenius Kabi serves nearly 450 million patients annually. Through its Vision 2026 strategy and broader #FutureFresenius initiative, the company is focused on developing new therapies and technologies, advancing patient care, and creating sustainable value.
Fresenius Kabi is part of the Fresenius Group, alongside Helios and Quirónsalud, working together to provide lifesaving and life-changing healthcare solutions worldwide.
